Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/13/2024RemeGen Unveils Phase III Study Results of Disitamab Vedotin in HER2-P...
  • 12/12/2024JPO Publicizes the Proposed Results of the 10th National VBP
  • 12/12/2024Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
  • 12/12/2024China to Invest $1B to Establish Medical City in Karachi
  • 12/12/2024Bayer Co.Lab Expands in China with Three New Biotech Partners
  • 12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia
  • 12/12/2024CSPC and BeOne Ink $1.835B Global License Deal for SYH2039
  • 12/12/2024Sunshine Lake Pharma Files for Hong Kong Listing
  • 12/12/2024CORXEL Enters Strategic Collaboration Agreement with Grand Pharma
  • 12/12/2024The State Council Issues China's HIV/AIDS Prevention and Control Plan ...
  • 12/12/2024Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
  • 12/11/2024Generative AI Powers Insilico Medicine's Rapid Development of New IBD ...
  • 12/11/2024Daiichi Sankyo Expands in China with $152M ADC Plant as Enhertu Gains ...
  • 12/11/2024Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
  • 12/11/2024South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
  • 12/11/2024Angitia Biopharma Announces $120M Series C Financing
  • 12/10/2024China and India to Lead Health Spending Growth in 2025 amid Emerging M...
  • 12/10/2024CU Medicine Partners with CTTQ to Propel Pharma Innovations in Hong Ko...
  • 12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
  • 12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
  • 12/10/2024Eisai's Dotinurad Approved in China for Gout
  • 12/10/2024Huadong and Kiniksa's Rilonacept Gains Approval in China for Recurrent...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
  • 12/10/2024Oxford Nanopore Sues Chinese Biotech Giant BGI Over Alleged Misuse of ...
  • 12/10/2024Hong Kong Takes Key Step Towards Becoming a Medical Hub with New Clini...
  • Page:6/42 Total number of articles:1245: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group